Key result
D-dimer cut-off of /L rules out acute pulmonary embolism with ~92% negative predictive value.
Why the study?
Safe exclusion and risk stratification are recommended for the initial management of acute pulmonary embolism, prompting evaluation of D-dimer testing at the beginning of admission.
Does D-dimer testing within 24 hours of admission safely exclude and stratify risk for acute pulmonary embolism in Chinese patients compared with disease controls?
Case-Control (n=141)
Blinded outcome assessment
No
Does D-dimer testing within 24 hours of admission safely exclude and stratify risk for acute pulmonary embolism in Chinese patients compared with disease controls?
Admission D-dimer testing (>1820 μg/L) demonstrates an AUC of 0.822 and a 91.6% negative predictive value, supporting its utility for excluding acute pulmonary embolism in primary care.
Answers are grounded in this paper and cite their sources.
D-dimer at 1820 μg/L may aid exclusion of acute pulmonary embolism; leaves open prospective validation before routine adoption.
BACKGROUND: Safe exclusion and risk stratification are currently recommended for the initial management of patients with acute pulmonary embolism (APE). The aim of this study was to assess the safe exclusion and risk stratification value of D-dimer (DD) for APE when tested at the beginning of admission. MATERIALS AND METHODS: All consecutive Chinese APE patients and controls were recruited from January 2010 to December 2012. All measurements of serum indexes were made in duplicate and blinded to the patients' status. All the 40 patients with the first episode of APE were confirmed by multi-detector computed tomographic pulmonary angiography. The plasma prothrombin time (PT), activated partial thromboplastin time, thrombin time, fibrinogen, and DD levels were measured within 24 h of admission. We used the Mann-Whitney U-test to determine the differences between groups and drew receiver operator characteristic curve to evaluate the indexes' value in the APE screening. RESULTS: The PT and DD in the APE group were significantly higher than those in the disease control group (P < 0.05). Taking PT and DD as the useful screening tests for APE and AUC was 0.765 and 0.822, respectively. DD yielded the higher screening efficiency, with DD >1820 μg/L as cut-off value, the sensitivity, specificity, positive and negative predictive value was 82.5%, 75.2%, 56.9%, and 91.6%, respectively. CONCLUSION: The patients with APE showed significant higher DD levels compared with disease controls, suggesting a negative qualitative DD test result can safely and efficiently exclude APE in primary care.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2015) conducted a case-control in Acute pulmonary embolism (n=141). Plasma D-dimer level (>1820 μg/L cut-off) vs. Non-APE pulmonary disease controls was evaluated on Diagnostic screening discrimination for acute pulmonary embolism (area under the ROC curve and predictive values at >1820 μg/L cut-off) (AUC 0.822 (sensitivity 82.5%, specificity 75.2%, PPV 56.9%, NPV 91.6%), p=<0.05). Plasma D-dimer testing at a /L cut-off excluded acute pulmonary embolism with 91.6% negative predictive value, 82.5% sensitivity, and an AUC of 0.822.
Synapse has enriched 10 related papers. Consider them for comparative context: